Symonds steps down as Novartis CFO, Kirsch takes over

Alok Saboo Welcome to this week’s roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) ...

Takeda in more trouble at home over recall of mislabeled vials

Eric Palmer Japan's Takeda has gotten into more local hot water over the recall earlier this year of a lot of its Alinamin-F5 dietary supplement sold in Japan for vitamin B1 deficiency. ...

Dual-eligibles bill sets up another pharma fight over Medicare rebates

Tracy Staton Democratic lawmakers in both houses of Congress are backing a new bill extending Medicaid-style rebates to low-income Medicare patients, saying the provision would save ...

Royalty Pharma ups Elan offer in battle over shareholder support

Ryan McBride Royalty Pharma has brought a fully financed offer for Elan to the table, poking a hole in the argument from Elan management about the bidder's ability to make a credible ...

UPDATED: GlaxoSmithKline measures 36-meter leap over placebo in Duchenne walking test

John Carroll GlaxoSmithKline investigator John Kraus reviewed the long-awaited mid-stage results for its Duchenne muscular dystrophy drug drisapersen this afternoon, revealing that ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS